A compelling case for central pathology review of multiparameter flow cytometry measurable residual disease results in Acute Myeloid Leukemia (AML) clinical trials: Data from the PALG-AML1/2016 multicenter randomized study
Agnieszka Wierzbowska(Medical University of Lodz), Gail J. Roboz(Cornell University), Krystyna Jagoda(Medical University of Silesia), Martyna Włodarczyk(Medical University of Silesia), Agnieszka Pluta, Karol Wójcik, Grzegorz Charliński(Nicolaus Copernicus University), Anna Kopińska(Medical University of Silesia), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Anna Czyż(Wroclaw Medical University), Janusz Hałka(Wojskowy Instytut Medycyny Lotniczej), Sylvie Freeman(University of Birmingham), Tomasz Wróbel, Magdalena Czemerska(Medical University of Lodz), Jolanta Parulska(Poznan University of Medical Sciences), Marek Hus(Medical University of Lublin), Krzysztof Woźniczka(Medical University of Silesia), Marta Sobas, Jonathan Canaani(NewYork–Presbyterian Hospital), Agata Obara(Holy Cross University), Katarzyna Dulik(The Maria Sklodowska-Curie National Research Institute of Oncology), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Zuzanna Nowicka(University of Łódź), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Lidia Gil(Poznan University of Medical Sciences), Maria Bieniaszewska(Gdańsk Medical University), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Krzysztof Gawroński(Medical University of Warsaw), Magdalena Dutka(Gdańsk Medical University), Małgorzata Raźny, Andrzej Szczepaniak(Poznan University of Medical Sciences), Tomasz Gromek(Medical University of Lublin), Pinkal Desai(Cornell University), Jolanta Woźniak(Instytut Hematologii i Transfuzjologi), Agata Majchrzak(Copernicus Memorial Hospital), Justin D. Kaner(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Jerzy Hołowiecki(Medical University of Silesia), Michał Soin(University of Łódź), Agnieszka Kopacz(University of Rzeszów), Donata Szymczak(Wrocław University of Science and Technology), Michal Bar‐Natan(NewYork–Presbyterian Hospital), Krzysztof Lewandowski(University of Gdańsk), Joanna Dziaczkowska(Medical University of Silesia), Michael Samuel(NewYork–Presbyterian Hospital), Marta Libura(Medical University of Warsaw)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k